Rekah Pharmaceutical Industry Ltd. (TLV: REKA)

TLV: REKA Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 17, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	156	169	176	266	306	228
Market Cap Growth	-19.34%	-3.96%	-33.89%	-13.13%	34.20%	-22.45%
Enterprise Value	300	338	321	420	441	334
Last Close Price	13.68	14.78	15.39	22.40	25.79	19.21
PE Ratio	20.26	-	-	40.12	28.33	57.17
PS Ratio	0.46	0.52	0.60	1.01	1.15	1.16
PB Ratio	0.95	1.08	1.08	1.54	1.85	1.47
P/TBV Ratio	1.60	1.90	1.39	1.90	1.90	1.49
P/FCF Ratio	11.79	10.01	5.48	34.59	-	-
P/OCF Ratio	6.94	5.95	4.50	12.55	27.11	6.72
EV/Sales Ratio	0.90	1.05	1.10	1.59	1.66	1.70
EV/EBITDA Ratio	6.16	13.00	9.27	11.73	10.86	11.32
EV/EBIT Ratio	18.55	116.43	24.20	32.49	21.10	26.50
EV/FCF Ratio	22.64	20.07	10.00	54.61	-	-
Debt / Equity Ratio	0.90	1.19	1.02	0.96	1.00	0.93
Debt / EBITDA Ratio	3.03	5.67	4.07	4.64	4.10	4.89
Debt / FCF Ratio	11.13	11.02	5.17	21.59	-	-
Asset Turnover	0.72	0.69	0.66	0.62	0.67	0.59
Inventory Turnover	2.90	2.56	2.35	2.12	2.36	1.76
Quick Ratio	0.89	1.01	1.06	1.30	1.17	1.25
Current Ratio	1.43	1.75	1.75	2.25	2.10	2.10
Return on Equity (ROE)	4.75%	-4.35%	-1.22%	3.91%	6.73%	1.80%
Return on Assets (ROA)	2.18%	0.39%	1.87%	1.88%	3.32%	2.36%
Return on Capital (ROIC)	3.09%	0.54%	2.48%	2.41%	4.14%	2.95%
Earnings Yield	4.66%	-4.10%	-1.16%	2.49%	3.53%	1.75%
FCF Yield	8.09%	9.99%	18.25%	2.89%	-2.40%	-4.04%
Dividend Yield	0.00%	-	-	3.87%	-	-
Buyback Yield / Dilution	-9.50%	-	-	-	-	-1.03%
Total Shareholder Return	-9.50%	-	-	3.87%	-	-1.03%

Source: S&P Capital IQ. Standard template. Financial Sources.